Viatris Inc (VTRS) is a Healthcare · Drug Manufacturers - Specialty & Generic company listed on NASDAQ. Price $16.95 (-1.05%), Market cap $19.19B, 52-week low–high $8.29 ~ $17.39.
Viatris Inc., together with its subsidiaries, operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East. It operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The company offers prescription brand drugs, generic drugs, complex generic drugs, and biosimilars. It also provides drugs in various therapeutic areas covering various noncommunicable and infectious diseases, including cardiovascular, CNS and anesthesia, dermatology, diabetes and metabolism, eye care, gastroenterology, immunology, oncology, and respiratory and allergy, as well as supp
Financial statements, price targets, institutional (13F) holdings and related news for Viatris Inc are updated in real time on BlackAll Trade.
Viatris Inc trades at $16.95 (-1.05%). Real-time quotes and charts are available on BlackAll Trade.
Viatris Inc has a market cap of about $19.19B.
Viatris Inc., together with its subsidiaries, operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, a